Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Post-COVID-19 With Hyperbaric Oxygen Therapy: a Randomized, Controlled Trial

NCT06267300 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT06267300
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06267300 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Post-COVID-19 With Hyperbaric Oxygen Therapy: a Randomized, Controlled Trial
Lead sponsor
Erasmus Medical Center
Phase
Phase 3
Overall status
Unknown status
Start date
October 1, 2024
Completion date
April 1, 2026
Enrollment
120 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

long covid, long covid19, post covid-19 condition, post covid-19 condition, unspecified, post-covid condition, post-covid syndrome, post-covid-19 syndrome